Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: Correlation with disease activity

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 2 II, 2000, Pages 353-357

  Pucci, Neri ^a   Lombardi, Enrico ^a   Novembre, Elio ^a   Farina, Silvia ^a   Bernardini, Roberto ^a   Rossi, Elisabetta ^a   Favilli, Tania ^a   Vierucci, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Atopic dermatitis; Eosinophil cationic protein; Eosinophil protein X; Eosinophils

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; ATOPIC DERMATITIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; URINALYSIS;

BLOOD PROTEINS; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT; LEUKOCYTE COUNT; MALE; RIBONUCLEASES; SEVERITY OF ILLNESS INDEX;

EID: 0033955962     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(00)90087-3     Document Type: Article

References (35)

1. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic disease. J Allergy Clin Immunol 1995;96:302-9.
2. Akdis CA, Akdis M, Simon H, Blaser K. Regulation of allergic inflammation by skin-homing T cells in allergic eczema. Int Arch Allergy Immunol 1999;118:140-4.
3. Hirohito K, Adolphson CR, Gleich GJ. Biology of eosinophil. In: Middleton E Jr, Ellis EF, Yunginger JW, Reed CE, Adkinson EN Jr, Busse WW. Allergy: principles and practice. St Louis: Mosby; 1998. p 242-60.
4. Weller P. The immunobiology of eosinophil. N Engl J Med 1991;324:1110-8.
5. Cottin V, Deviller P, Tardy F, Cordier JF. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo. J Allergy Clin Immunol 1998;101:116-23.
6. Gleich GJ, Adolphson CR, Leiferman KM. Eosinophil. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven Press; 1992. p. 663-700.
7. Ott NL, Gleich GJ, Peterson EA, Fujisawa T, Sur S, Leiferman KM. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J Allergy Clin Immunol 1994;94:120-8.
8. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ. Dermal deposition of eosinophil-granule major basic protein in atopic dematitis: comparison with onchcoerciasis. N Engl J Med 1985;313:282-5.
9. Cheng JF, Ott NL, Peterson EA, et al. Dermal eosinophils in atopic dermatitis undergo cytolitic degeneration. J Allergy Clin Immunol 1997;99:683-92.
10. Rosenberg HF. Recombinant human eosinophil cationic protein. J Biol Chem 1995;270:7878-81.
11. Hamann KJ, Ten RM, Loegering DA, et al. Structure and chromosomal localization of the human-eosinophil-derived neurotoxin and eosinophil-cationic protein genes: evidence for intronless coding sequences in the RNase gene superfamily. Genomics 1990;7:535-46.
12. Paganelli R, Fanales-Belasio E, Carmini D, et al. Serum eosinophil cationic protein in patients with atopic dermatitis. Arch Allergy Appl Immunol 1991;96:175-8.
13. Furue M, Sugiyama H, Tsukamoto K, Ohtake N, Tamaki K. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis. J Dermatol Sci 1994;7:89-95.
14. Halmerbauer G, Frischer T, Koller DY Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood. Allergy 1997;52:765-9.
15. Kägi MK, Joller-Jermelka H, Wüthrich B. Correlation of eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992;185:88-92.
16. Czech W, Krutmann J, Schöpf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992;126:351-5.
17. Kay J, Gawkrodger DJ, Marek J, et al. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994;30:35-9.
18. Musgrove K, Morgan JK. Infantile eczema. Br J Dermatol 1976;95:365-72.
19. Kristjánsson S, Strannegård IL, Strannegård Ö, et al. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. J Allergy Clin Immunol 1996;97:1179-87.
20. Lugosi E, Halmerbauer G, Frischer T, Koller DY. Urinary eosinophil protein X in relation to disease activity in childhood asthma. Allergy 1997;52:584-8.
21. Shirikawa S, Iwasaki E, Miyabayashi Y, Baba M. Serum eosinophil cationic protein, urinary eosinophil protein X and urinary N-methylhistamine during acute asthma in children. Arerugi 1998;47:1240-7.
22. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh) 1980;92:44-7.
23. Severity scoring of atopic dermatitis: the SCORAD Index. Consensus report of the European Task Force on atopic dermatitis. Dermatology 1993;186:23-31.
24. The European Academy of Allergology and Clinical Immunology. Position paper: Allergen standardization and skin tests. Allergy 1993;48:48-82.
25. Marks GB, Kjellerby J, Luczynska CM, Burney PG. Serum eosinophil cationic protein: distribution and reproducibility in randomly selected sample of men living in rural Norfolk, UK. Clin Exp Allergy 1998;28:1345-50.
26. Fujisawa T, Terada A, Atsuta J, Iguchi K, Kamiya H, Sakurai M. Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma. Clin Exp Allergy 1998;28:19-25.
27. Vanto T, Koskinen P. Serum eosinophil cationic protein in the evaluation of asthma severity in children. Allergy 1998;53:415-9
28. Kapp A. The role of eosinophils in the pathogenesis of atopic dermatitis-eosinophil granule proteins as markers of disease activity. Allergy 1993;48:1-5
29. Schauer U, Trube M, Jager R, Gieler U, Rieger CHL. Blood eosinophils, eosinophil-derived proteins, and leukotriene C4 generation in relation to bronchial hyperreactivity in children with atopic dermatitis. Allergy 1995;50:126-32.
30. Reimert CM, Ouma JH, Mwanje MT, et al. Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX). Acta Trop 1993;54:1-12.
31. Deviller P, Gruart V, Prin L, et al. Detection of an eosinophil derivated neurotoxin in the urine of a patient with idiopatic chronic eosinophilic pneumonia. Clin Chim Acta 1991;201:105-12.
32. Cottin V, Deviller P, Tardy F, Cordier JF. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo. J Allergy Clin Immunol 1998;101:116-23.
33. Oosaki R, Mizushima Y, Kawasaki A, Mita H, Akijama K, Kobajashi M. Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack. Clin Exp Allergy 1998;28:1138-44.
34. Beltrani VS. The clinical manifestations of atopic dematitis. In: Leung DYM, editor. Atopic dermatitis: from pathogenesis to treatment. Austin (TX): RG Landes; 1996.
35. Sur S, Glitz DG, Kita H, et al. Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic granulocytes. J Leukoc Biol 1988;63:715-22.